Rotavirus Vaccine Market Soars: Projected to Hit USD 22,750 Million by 2030

The global rotavirus vaccine market has shown substantial growth over recent years, reflecting the increased focus on combating rotavirus infections worldwide. In 2021, the market was valued at USD 9,053 million and is projected to reach USD 22,750 million by 2030, growing at a compound annual growth rate (CAGR) of 11% from 2022 to 2030. This growth is driven by multiple factors, including the rising prevalence of rotavirus infections, an increase in the number of individuals with weakened immune systems, and a growing elderly population. However, the market also faces challenges, such as uncertain demand from non-GAVI middle-income countries (MICs) and concerns about the potential negative effects of the vaccines.

REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2784

Market Drivers:

1. Growing Prevalence of Rotavirus Infection Among Children: Rotavirus is a leading cause of severe diarrhea and dehydration in infants and young children globally. Despite the availability of vaccines, rotavirus infections remain a significant public health issue, particularly in low- and middle-income countries. The high prevalence of the infection necessitates widespread immunization programs, which in turn drive the demand for rotavirus vaccines. Governments and international health organizations are increasingly focusing on expanding vaccination coverage to reduce the morbidity and mortality associated with rotavirus infections.
2. Rise in the Number of People with Weakened Immune Systems: The growing number of individuals with compromised immune systems, due to conditions such as HIV/AIDS, cancer, and the use of immunosuppressive drugs, increases the susceptibility to rotavirus infections. This demographic requires effective preventive measures, including vaccination, to mitigate the risk of severe outcomes. As the global population with weakened immune systems continues to rise, the demand for rotavirus vaccines is expected to grow correspondingly.
3. Increase in the Elderly Population: Although rotavirus primarily affects young children, adults, particularly the elderly, can also be susceptible to infections, especially in community settings such as nursing homes. The aging global population presents a growing target demographic for rotavirus vaccination programs, further bolstering market growth.

Download Sample Report Copy of This Report from Here: https://www.acumenresearchandconsulting.com/request-sample/2784

Market Restraints:

1. Uncertain Demand from Non-GAVI MICs: Middle-income countries that are not part of the Global Alliance for Vaccines and Immunization (GAVI) face unique challenges in implementing widespread vaccination programs. These countries often struggle with limited healthcare budgets and competing health priorities, leading to uncertain demand for rotavirus vaccines. Additionally, the variability in government commitment and healthcare infrastructure can hinder the consistent uptake of vaccination programs in these regions.
2. Concerns About Vaccinations' Negative Effects: Despite the proven benefits of rotavirus vaccines, concerns about potential side effects and vaccine safety can influence public perception and acceptance. Rare adverse events, such as intussusception (a type of bowel blockage), though infrequent, can deter vaccine uptake and pose challenges for healthcare providers in convincing parents and caregivers of the vaccine's safety. Addressing these concerns through robust safety monitoring and effective communication strategies is crucial for maintaining public trust and ensuring high vaccination coverage.

Market Opportunities:

1. Increase in the Overall Population and Live Births: The global population is continuously growing, and with it, the number of live births. This demographic trend directly influences the demand for pediatric vaccines, including rotavirus vaccines. As more infants are born each year, the need for comprehensive immunization programs becomes increasingly important to protect against preventable diseases. This presents a significant growth opportunity for the rotavirus vaccine market, particularly in regions with high birth rates.
2. Advancements in Vaccine Development: Ongoing research and development efforts in the field of vaccinology are likely to yield new and improved rotavirus vaccines. Innovations such as vaccines with broader strain coverage, enhanced efficacy, and improved safety profiles can drive market growth. Additionally, the development of thermostable vaccines that do not require strict cold chain storage could facilitate easier distribution and administration in remote and resource-limited settings.
3. Government and International Support: Increased support from governments and international organizations for vaccination programs can significantly boost the rotavirus vaccine market. Initiatives such as funding for vaccine procurement, subsidies, and public awareness campaigns play a crucial role in increasing vaccination rates. Collaborations between public and private sectors to enhance vaccine accessibility and affordability are also expected to positively impact market growth.

Rotavirus Vaccine Market Segmentation

Market by Type
• Lanzhou Lamb
• Rotarix
• Rotavac
• Rotavin-M1
• Others

Market by End-Use
• Hospitals
• Clinics
• Academic & Research Lab

Regional Market Insights:

The rotavirus vaccine market is geographically diverse, with varying levels of vaccine adoption and coverage across different regions. North America and Europe have historically been the largest markets due to established healthcare infrastructure, high awareness, and government support. However, significant growth opportunities exist in Asia-Pacific, Latin America, and Africa, where rotavirus infection rates are high, and vaccination coverage is still expanding.

1. North America: In North America, the rotavirus vaccine market benefits from robust healthcare systems, extensive vaccination programs, and supportive government policies. High awareness among parents and healthcare providers contributes to the region's strong market position.
2. Europe: Europe follows a similar trend with widespread adoption of rotavirus vaccines, driven by national immunization programs and strong healthcare infrastructure. Countries such as the UK, Germany, and France are major contributors to the regional market.
3. Asia-Pacific: The Asia-Pacific region presents significant growth potential due to its large population and high birth rates. Efforts to expand vaccination programs in countries like India, China, and Indonesia are expected to drive market growth. International support and partnerships play a crucial role in enhancing vaccine accessibility in this region.
4. Latin America: Latin America has seen improvements in vaccination coverage, but challenges remain in ensuring consistent access across all socio-economic groups. Countries like Brazil and Mexico are key markets in the region, supported by government initiatives to increase immunization rates.
5. Middle East and Africa: The Middle East and Africa face the highest burden of rotavirus infections and the greatest need for effective vaccination programs. Efforts to improve healthcare infrastructure, increase awareness, and secure funding for vaccines are critical for market growth in these regions.

Rotavirus Vaccine Market Players

Some of the prominent global rotavirus vaccine market companies are BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bharat Biotech, Biological E, Bio Farma, Novartis AG, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, Berghofer Medical Research Institute, and Pfizer, Inc.

Competitive Landscape:

The global rotavirus vaccine market is competitive, with several key players striving to enhance their market position through product innovation, strategic partnerships, and expansion into emerging markets. Major companies operating in this market include GlaxoSmithKline plc, Merck & Co., Inc., Bharat Biotech, and Sanofi Pasteur, among others. These companies are engaged in continuous research and development activities to improve vaccine formulations, expand their product portfolios, and address unmet medical needs.

Rotavirus Vaccine Market Table of Content:

CHAPTER 1. Industry Overview of Rotavirus Vaccine Market
CHAPTER 2. Research Approach
CHAPTER 3. Market Dynamics And Competition Analysis
CHAPTER 4. Manufacturing Plant Analysis
CHAPTER 5. Rotavirus Vaccine Market Revenue By Type
CHAPTER 6. Rotavirus Vaccine Market Revenue By End-Use
CHAPTER 7. North America Rotavirus Vaccine Market By Country
CHAPTER 8. Europe Rotavirus Vaccine Market By Country
CHAPTER 9. Asia-Pacific Rotavirus Vaccine Market By Country
CHAPTER 10. Latin America Rotavirus Vaccine Market By Country
CHAPTER 11. Middle East & Africa Rotavirus Vaccine Market By Country
CHAPTER 12. Player Analysis Of Rotavirus Vaccine Market
CHAPTER 13. Company Profile

Conclusion:

The global rotavirus vaccine market is poised for substantial growth over the coming years, driven by the increasing prevalence of rotavirus infections, rising demand from vulnerable populations, and advancements in vaccine development. While challenges such as uncertain demand in non-GAVI MICs and concerns about vaccine safety need to be addressed, significant opportunities exist in expanding vaccination coverage and enhancing global health outcomes. The concerted efforts of governments, international organizations, and industry players will be crucial in achieving these goals and ensuring a healthier future for children worldwide.

Ask Query Here: Richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/2784

Browse for more Related Reports
https://www.globenewswire.com/news-release/2022/07/11/2477425/0/en/Rotavirus-Vaccine-Market-Size-is-Projected-to-Reach-USD-22-750-Million-by-2030-at-a-CAGR-of-11-Pushed-by-Rising-Occurrence-of-Rotavirus-Infection-Among-Children.html

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

This release was published on openPR.